Matthew Perrone
Daily Freeman
Washington, DC, United States
Contact Matthew
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Matthew:
Juul to pay nearly $440M to settle states’ teen vaping probe
HARTFORD, Conn. (AP) — Electronic cigarette maker Juul Labs has agreed to pay nearly $440 million to settle a two-year investigation by 33 states into the marketing of its high-nicotine vapin… → Read More
Under fire, US officials say monkeypox can still be stopped
WASHINGTON (AP) — The country’s monkeypox outbreak can still be stopped, U.S. health officials said Thursday, despite rising case numbers and so far limited vaccine supplies. → Read More
US signs off on 800,000 more doses of monkeypox vaccine
WASHINGTON (AP) — After weeks of delays, nearly 800,000 doses of the monkeypox vaccine will soon be available for distribution, U.S. health regulators said Wednesday. → Read More
FDA bans Juul e-cigarettes tied to teen vaping surge
WASHINGTON (AP) — Federal health officials on Thursday ordered Juul to pull its electronic cigarettes from the U.S. market, the latest blow to the embattled company widely blamed for sparking… → Read More
US: Pfizer COVID-19 shot appears effective for kids under 5
WASHINGTON (AP) — Federal health officials said Sunday that kid-sized doses of Pfizer’s COVID-19 vaccines appear to be safe and effective for kids under 5, a key step toward a long-awai… → Read More
FDA chief under fire for slow response to baby formula issue
WASHINGTON (AP) — The head of the Food and Drug Administration faced bipartisan fury from House lawmakers Wednesday over months of delays investigating problems at the nation’s largest … → Read More
EXPLAINER: What’s behind the baby formula shortage?
WASHINGTON (AP) — Many parents are hunting for infant formula because of a combination of short- and long-term problems that has hit most of the biggest U.S. brands. → Read More
Parents hunting for baby formula as shortage spans US
WASHINGTON (AP) — Parents across the U.S. are scrambling to find baby formula because supply disruptions and a massive safety recall have swept many leading brands off store shelves. → Read More
FDA OKs another Pfizer, Moderna COVID booster for 50 and up
U.S. regulators on Tuesday authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection for the most vulnerable in case the coronavirus rebounds. → Read More
Delay ahead for Pfizer’s COVID-19 vaccine for kids under 5
WASHINGTON (AP) — U.S. regulators on Friday put the brakes on their push to speed Pfizer’s COVID-19 to children under 5, creating major uncertainty about how soon the shots could become… → Read More
Pfizer asks FDA to allow COVID-19 vaccine for kids under 5
WASHINGTON (AP) — Pfizer on Tuesday asked the U.S. to authorize extra-low doses of its COVID-19 vaccine for children under 5, potentially opening the way for the very youngest Americans to st… → Read More
Moderna announces full US approval for its COVID-19 vaccine
WASHINGTON (AP) — Moderna announced Monday that U.S. health regulators granted full approval to its COVID-19 vaccine, a shot that’s been given to tens of millions of Americans since its… → Read More
US begins offering 1B free COVID tests, but many more needed
WASHINGTON (AP) — For the first time, people across the U.S. can log on to a government website and order free, at-home COVID-19 tests. But the White House push may do little to ease the omic… → Read More
US adds Merck pill as 2nd easy-to-use drug against COVID-19
WASHINGTON (AP) — U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections. → Read More
Pfizer pill becomes 1st US-authorized home COVID treatment
WASHINGTON (AP) — U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of th… → Read More
FDA expands Pfizer COVID booster, opens extra dose to age 16
The U.S. is expanding COVID-19 boosters, ruling that 16- and 17-year-olds can get a third dose of Pfizer’s vaccine. → Read More
US expands COVID boosters to all adults, final hurdle ahead
WASHINGTON (AP) — U.S. regulators on Friday opened up COVID-19 booster shots to all adults, expanding the government’s campaign to shore up protection and get ahead of rising coronaviru… → Read More
Biden picks former FDA chief Califf to again lead the agency
WASHINGTON (AP) — President Joe Biden on Friday is tapping former Food and Drug Administration commissioner Robert Califf to again lead the powerful regulatory agency, according to a person f… → Read More
Pfizer says COVID-19 pill cut hospital, death risk by 90%
WASHINGTON (AP) — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joins th… → Read More
FDA paves way for Pfizer COVID-19 vaccinations in young kids
WASHINGTON (AP) — The Food and Drug Administration on Friday paved the way for children ages 5 to 11 to get Pfizer’s COVID-19 vaccine. → Read More